SuperworthMimedx shares outstanding MDXG
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 147.8M
- On a year earlier
- −1.0%
- fewer shares
Mimedx had 147.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.0% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 150.2M | +1% |
| FY2024 | 149.3M | −36% |
| FY2023 | 232.2M | +104% |
| FY2022 | 113.7M | +2% |
| FY2021 | 111M | +2% |
| FY2020 | 108.4M | +1% |
| FY2019 | 107M | −2% |
| FY2018 | 109.1M | −4% |
| FY2016 | 113.2M | +1% |
| FY2015 | 112.2M | −3% |
| FY2014 | 115.6M | +17% |
| FY2013 | 98.8M | +33% |
| FY2012 | 74.4M | +1% |
| FY2011 | 73.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 147.8M | −1% | |
| Q1 FY26 | 148.4M | −1% | |
| Q4 FY25 | 150.2M | +1% | |
| Q3 FY25 | 149.7M | +1% | |
| Q2 FY25 | 149.3M | +0% | |
| Q1 FY25 | 149.7M | −0% | |
| Q4 FY24 | 149.3M | −36% | |
| Q3 FY24 | 148.4M | −1% | |
| Q2 FY24 | 148.9M | +1% | |
| Q1 FY24 | 150M | +31% | |
| Q4 FY23 | 232.2M | +104% | |
| Q3 FY23 | 149.8M | +32% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Mimedx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.